榜单｜2022年25位顶尖女高管Top25WomenLeadersinMedicalDevices｜人物(19)

Before joining Edwards, Szyman spent over 20 years at Medtronic, ultimately serving as its senior vice president and president of the global diabetes business, overseeing research, development, operations, sales, and marketing for the company’s insulin infusion pumps and continuous glucose monitoring systems. She serves on the boards of Outset Medical, Inari Medical, and the Edwards Lifesciences Foundation. Szyman graduated from the University of St. Thomas with a bachelor’s degree in accounting and international business, and subsequently earned her Master of Business Administration from Harvard Business School.
Katie Szyman是Edwards Lifesciences的公司副总裁兼重症监护总经理，Edwards Lifesciences是重症监护和手术监测以及结构性心脏病以患者为中心的创新的全球领导者。自 2015 年加入 Edwards 以来，Szyman 将新技术推向市场，每年影响数百万患者的生活。她启动了业务的转变，从描述性监测产品转向预测性和人工智能驱动的产品和智能恢复技术，帮助临床医生做出决策，目标是帮助患者更快地回家与家人团聚。
在加入 Edwards 之前，Szyman 在美敦力工作了 20 多年，最终担任其高级副总裁兼全球糖尿病业务总裁，负责监督公司胰岛素输液泵和连续血糖监测系统的研究、开发、运营、销售和营销。她是Outset Medical，Inari Medical和Edwards Lifesciences Foundation的董事会成员。Szyman毕业于圣托马斯大学，获得会计和国际商务学士学位，随后在哈佛商学院获得工商管理硕士学位。